We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Event

Conference on Serious Adverse Events (SAEs): What it is and How to Handle

Serious Adverse Events (SAEs): What it is and How to Handle

Overview: When conducting clinical trials it is important to understand and be able to identify serious adverse events (SAE). These are events that are serious, likely related to the study drug, device, treatment or procedure, and increase risks to participants or others.Serious adverse events are defined by the FDA as "Any adverse experience that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse experience as it occurred, i.e., it does not include an adverse drug experience that, had it occurred in a more severe form, might have caused death." Although this definition seems clear, there are words within the definition itself that have to be understood in order to ensure compliance. Who is the initial reporter? What is an adverse experience? Is an adverse experience different or the same as an adverse drug experience? How do you know if a more severe form as occurred? Is death the SAE or is the cause of death the SAE?This webinar will help sort out all these issues and get you to a better understanding of what needs to be reported to who.Why should you attend: Regulations and guidance can be overwhelming and seem conflicting when it comes to handling serious adverse events, it is important to know when and what needs to be submitted, reviewed, and approved by an Institutional Review Board (IRB) and what can be handled by the investigator as non-reporting of events that are considered reportable can lead to issues related to non-compliance.Areas Covered in the Session:ICH guidelines and Good Clinical Practice (GCP)Department of Health and Human Services (DHHS) guidanceFood and Drug Administration (FDA) guidanceDefinitionsPotential effects on consent and the protocolExamplesLinks to useful resourcesWho Will Benefit:Human Subjects ResearchHealthcare interested in exploring the field of Clinical ResearchNew Clinical Research Coordinator Positions (1-2 years)New Principal Investigator PositionsAdministration in charge of Clinical ResearchRegulatory CompliancePrice : $139.00Contact Info:MentorHealthPhone No: 1-800-385-1607FaX: 302-288-6884

When

3 Dec 2015 @ 10:00 am

3 Dec 2015 @ 11:00 am

Duration: 1 hours

Timezone: GMT -5:00


Where

Online Webinar


Language

Englishen


Organised by

NetZealous (deactivated)

Premium Events in Health

Other Events in Health

AgeingFIT 2022

France, 1 Mar 2022

Similar Webinars in Health

Recent Publications in Health

Recent Videos in Health

Recent Speakers in Health

Steven Walfish
Researcher

5

Gilles Vassal
Board Member

1

Douglas N. Ishii
Key Note

1

Sponsors in Health

Recent News in Health

🧵The new Regulation on transmissible #AnimalDiseases, #AnimalHealthLaw, comes into play on 21 April. It aims to hel… https://t.co/l8c2xvKaQf

@EFSA_EU - 21 Apr 2021 09:28

#AnimalHealthEU https://t.co/r18horFWHW

@Food_EU - 21 Apr 2021 08:47

A more flexible and comprehensive Animal Health Law enters into force today We have streamlined a huge number of l… https://t.co/zvcqDbVQT1

@Food_EU - 21 Apr 2021 08:40

Premium EventsLearn more ..